Director, Strategic Site Partnerships – Cell Therapy

Introduction to Role As Director, Strategic Site Partnerships – Cell Therapy, you will serve as the accountable leader for AstraZeneca’s end-to-end relationship with a defined portfolio of priority cell therapy sites. You will combine strategic alliance leadership with clinical and operational expertise to translate enterprise priorities into integrated site strategies, coordinated action, stronger portfolio execution, and lasting partnerships spanning scientific collaboration, early clinical development, and launch readiness. As AstraZeneca’s strategic point of contact for select Cell Therapy Strategic Partnership Sites, you will align the Alliance Joint Steering Committee (JSC), investigators, site leadership, and AstraZeneca’s cross-functional partnership team around shared priorities, clear accountabilities, and measurable outcomes. You will help remove barriers across the patient and site journey, enable high-quality clinical trial delivery, and ensure site insights inform decisions across the broader cell therapy portfolio. Why This Role This is an opportunity to shape high-impact partnerships at the forefront of cell therapy and oncology. You will represent the breadth of AstraZeneca’s cell therapy portfolio at the site level, strengthen collaboration with leading treatment centers, and help improve activation timelines, enrollment, protocol adherence, patient access, and site experience. By creating a continuous feedback loop between strategic sites and global teams, you will identify recurring barriers early and help convert site-level insights into scalable solutions. Your leadership will support clinical development today while preparing strategic sites for future programs, new indications, and clinical-to-commercial transitions. Accountabilities Strategic Site Ownership and Governance Serve as Alliance Manager for the Cell Therapy Strategic Partnership Joint Steering Committee. Act as the primary AstraZeneca relationship owner and enterprise-level escalation point for assigned strategic sites across the cell therapy portfolio. Partner with the Senior Director, Cell Therapy Partnership and Strategy and the Strategic Partnership Joint Steering Committee to develop and maintain a multi-year site partnership plan. Integrate clinical development priorities, site capabilities, mutual value, risks, and readiness for future programs into a cohesive site strategy. Lead joint governance and executive-level partnership reviews with clear agendas, decisions, actions, owners, and follow-through. Ensure required internal governance approvals are obtained. Build trusted relationships with site leadership, investigators, cell therapy program leaders, research operations, pharmacy, apheresis, inpatient and outpatient care teams, and administrative stakeholders. Maintain a comprehensive view of AstraZeneca’s portfolio and engagement at each site. Coordinate the timing and sequencing of site interactions to reduce duplication, conflicting requests, and relationship fatigue. Lead the cross-functional site partnership team, mobilize the appropriate AstraZeneca expertise, clarify accountabilities, and drive coordinated execution. Portfolio Execution and Performance Establish an integrated site performance plan across active and planned studies, with clear priorities, performance measures, and proposed mitigations. Support improvements in site activation, enrollment, patient flow, retention, protocol adherence, patient access, site experience, and issue resolution. Partner with Clinical Development, Study Management, Site Management and Monitoring, Patient Operations, Supply and Logistics, Country Operations, and other functions to identify root causes and accelerate the resolution of cross-study barriers. Use performance data and site intelligence to identify emerging risks, distinguish local challenges from systemic patterns, and focus resources where intervention can have the greatest portfolio impact. Track commitments, risks, actions, and outcomes through a consolidated partnership dashboard. Provide concise, decision-oriented updates to AstraZeneca and site senior leaders. Inform feasibility and site selection through an enterprise view of site capacity, competing clinical trials, patient access, investigator interest, and operational readiness. Clinical Field Leadership and Protocol Enablement Maintain deep working knowledge of AstraZeneca’s cell therapy portfolio, protocols, patient populations, treatment pathways, and site delivery requirements. Partner with assigned sites and AstraZeneca’s cross-functional teams to assess protocol and educational needs. Coordinate targeted, compliant education with the appropriate study, clinical, and medical experts. Help sites translate complex eligibility criteria, safety requirements, care pathways, and operational procedures into practical workflows that support appropriate patient identification and high-quality execution. Identify drivers of screen failure, protocol deviation, patient attrition, and treatment delays. Facilitate cross-functional root-cause analysis and the development of sustainable corrective actions. Escalate medical, safety, or protocol interpretation questions through established channels and help ensure sites receive coordinated and timely responses. Enterprise Insights and Continuous Improvement Capture structured insights related to referral pathways, patient access, site capacity, protocol feasibility, operational burden, and the end-to-end patient journey. Synthesize themes across sites and studies, quantify their impact where possible, and recommend portfolio-level improvements to protocols, processes, tools, and resource deployment. Share site best practices across the strategic site network. Partner with global teams to scale solutions that improve speed, quality, and consistency across the cell therapy portfolio. Bring an external perspective on the evolving cell therapy landscape, competitive clinical trial activity, and site operating models while maintaining compliant scientific exchange. Create a continuous feedback loop between strategic sites and global teams so recurring barriers are identified early and translated into scalable portfolio-level solutions. Long-Term Partnership and Launch Readiness Partner with Medical, Commercial, Development, Manufacturing, Market Access, and Patient Services to assess strategic-site readiness for future indications and potential launches while maintaining appropriate role boundaries. Support strategically aligned and appropriately governed initiatives involving referral-network development, workforce and capacity planning, clinical-to-commercial continuity, data collaborations, education, and innovation. Represent AstraZeneca at selected scientific meetings, investigator forums, and partnership events to strengthen engagement and advance agreed site objectives. Help strategic sites prepare for upcoming programs, new indications, and clinical-to-commercial transition milestones. Role Accountability and Functional Partnership The Director is accountable for: Site relationship: The integrated site strategy, relationship health, governance, stakeholder map, engagement sequencing, and enterprise-level escalation. Cross-functional coordination: Convening the site partnership team, clarifying owners and timelines, and driving closure of issues that cross studies or functions. Performan